Conference Biological Medicines – legal aspects at UKSW

In December 2019 took place an annual nationwide scientific conference, organized by UKSW University in Warsaw, faculty of Law and Administration. Monika Duszyńska led the first panel, entitled „Patient under a biological treatment’’. The panel was attended, among others, by Prof. Marcin Czech and Paweł Grzesiewski, Director of Legal Affairs at the office of the [...]

By |2021-11-24T23:06:13+01:00December 22nd, 2019|News & Insights|0 Comments

Attending an expert debate on biological treatment and patient rights

On 24 June 2019, at a experts' debate on biological treatment and patients' rights, Monika Duszyńska presented her position. She emphasized that the judgment of the Supreme Administrative Court on the substitution of biological medicines sets new standards in use of biologicals in hospitals and is a court precedent. Monika represented patients in this matter [...]

By |2024-03-18T14:56:48+01:00June 25th, 2019|News & Insights|0 Comments

Monika Duszyńska represents PUOP in front of the NSA; important judgment on the substitution of biological drugs

On 28th of May, Supreme Administrative Court (NSA) passed a judgement which confirmed the decision of Provincial Administrative Court(WSA) in Warsaw and supporting decision of the Patients Ombudsman. The Patients Ombudsman claimed that the practise of one of the hospitals which consist of determining which biological medicine received patient on the result of the auction, [...]

By |2022-08-02T14:56:34+02:00May 29th, 2019|News & Insights|0 Comments

Ranking Chambers&Partners 2019

In this year's edition of the international legal ranking by Chambers & Partners Europe, in the Lifesciences category, Monika is still listed in the second group of individual lawyers. Head of practice Monika Duszyńska of Monika Duszyńska Kancelaria Adwokacka is praised to have "great understanding of the business".    

By |2024-07-15T15:21:25+02:00March 15th, 2019|News & Insights|0 Comments

A seminar devoted to the substitution of biological drugs

The discussion on the substitution of biological medicines still raises a lot of controversy and doubts. A scientific seminar "Substitution – Replacement - Switch of biological drugs" held on 18 June 2018, was devoted to this topic. One of the speakers was Monika Duszyńska, who talked on EU guidelines and practices of selected regulatory agencies [...]

By |2021-11-24T22:27:08+01:00June 19th, 2018|News & Insights|0 Comments
Go to Top